PubRank

John Mandeli

Author PubWeight™ 26.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma. J Clin Oncol 2008 2.40
2 Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol 2011 2.39
3 Retracted A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer. J Natl Cancer Inst 2008 1.84
4 Lymph node ratio as a prognostic factor in elderly patients with pathological N1 non-small cell lung cancer. Thorax 2010 1.80
5 Retracted The oncopathic potency of Clostridium perfringens is independent of its alpha-toxin gene. Hum Gene Ther 2009 1.70
6 Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002 1.52
7 rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy. Hum Gene Ther 2008 1.13
8 Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment. J Clin Oncol 2006 1.03
9 Rejection of metastatic 4T1 breast cancer by attenuation of Treg cells in combination with immune stimulation. Mol Ther 2007 0.99
10 Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. Oncologist 2005 0.96
11 Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells. Oncol Rep 2007 0.94
12 Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model. J Natl Cancer Inst 2006 0.90
13 Assessment of inspiratory flow limitation in children with sleep-disordered breathing by a nasal cannula pressure transducer system. Pediatr Pulmonol 2002 0.90
14 Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study. Gynecol Oncol 2004 0.85
15 Downstaging cancer in rural Africa. Int J Cancer 2014 0.85
16 KLF6 loss of function in human prostate cancer progression is implicated in resistance to androgen deprivation. Am J Pathol 2012 0.83
17 Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal. Ann Surg Oncol 2014 0.82
18 Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study. Gynecol Oncol 2005 0.80
19 Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice. Genes Cancer 2011 0.79
20 Prognostic Role of Immune Cells in Hepatitis B-associated Hepatocellular Carcinoma Following Surgical Resection Depends on Their Localization and Tumor Size. J Immunother 2016 0.78
21 Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma. Am J Hematol 2010 0.77
22 A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells. Proc Natl Acad Sci U S A 2004 0.76
23 Retraction: A genetically enhanced anaerobic bacterium for oncopathic therapy of pancreatic cancer. J Natl Cancer Inst 2010 0.75
24 Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group. J Clin Oncol 2004 0.75
25 13-cis retinoic acid and complete androgen blockade in advanced hormone-naive prostate cancer patients: report of a phase II randomized study. J Clin Oncol 2002 0.75
26 Transformation of NIH 3T3 cells by enhanced PAR expression. Biochem Biophys Res Commun 2004 0.75
27 Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease. Ann Surg Oncol 2012 0.75
28 Decision-Making in Breast Cancer Surgery: Where Do Patients Go for Information? Am Surg 2016 0.75
29 Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization. Cytotherapy 2009 0.75
30 PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins. Int J Oncol 2011 0.75